988 resultados para Lesão periférica de células gigantes. RANK
Resumo:
The Giant Cell Lesions, both the Central Giant Cells Lesions (CGCL) as the Peripheral Giant Cells Lesions (PGCL), correspond to a group of oral lesions that are histologically similar entities; however they show a variable clinical behaviour. The purpose of this study was to compare the immunohistochemical expression of bone resorption factors RANK (Receptor Activator of Nuclear Factor kappa B), RANKL (Receptor Activator of Nuclear Factor kappa B Ligand) and OPG (Osteoprotegerin) between CGCL and PGCL. Additionally, these bone resorption factors were examined in terms of aggressiveness of these lesions. The sample consisted of 61 cases, 30 cases of PGCL and 31 CGCL (16 non-aggressive and 15 aggressive). The analysis was performed by quantification of mononuclear cells (MO) and giant multinucleated cells (CG) immunopositive to anti-RANK, anti-RANKL and anti-OPG antibodies in 10 fields. Moreover, according to the proportion between the amount of cells positive for RANKL and OPG, the cases were categorized into: RANKL>OPG, OPG>RANKL e RANKL=OPG. CGCL showed a higher amount of MO (p=0.002) and total cells (p=0.003) both positives to RANKL compared with the PGCL. Additionally, the CGCL revealed a significant association with the ratio of RANKL>OPG (p=0.001). Analysis of the bone resorption factors revealed no significant differences between aggressive and non-aggressive CGCL (p>0.05). It was observed a positive correlation between the markers themselves, and a negative correlation between lesion size and quantity of OPG positive MO cells (p=0,004) and total cells (p=0,009). Through these results, we suggest that the greatest CGCL resorptive potential compared to the PGCL, may have occurred to the high expression of RANKL. Furthermore differences in the biological behavior of aggressive and non-aggressive CGCL appear to be related to the expression of these bone resorption factors
Resumo:
The peripheral giant cell lesion ( PG CL ) and the central giant cell lesion ( CGC L) are lesions histologically similar affecting the head and neck region . The study aimed to analyze the immunohistochemical expression of markers GLUT - 1 , GLUT - 3 and M - CSF in a series of cases of PGCL and CGCL , in trying to understand the different biological behavior of these pathologies . The sample consisted of 20 tissue specimens of PGCL 20 central lesion of not aggressive giant cell ( CLNAGC) and 20 central lesi on of aggressive giant cell ( CLAGC), coming from the Pathology Unit of Oral Pathology of the Department of Dentistry of UFRN . W as performed the s emi - quantitative and qualitative analysis of immunohistochemical expression of the markers in giant cells and m ononuclear cells . In relation to the GLUT - 1, it was found a statistically significant difference (p < 0.05) in the number of mononuclear cells immunomarked between the PGCL and the CLNAGC and between the PGCL and CLAGC . Regarding the intensity of staining w as also observed a statistically significant difference both at the mononuclear cells as in giant cells between PL and CLNAGC and between PGCL and CLAGC , at the giant cells there was also a statistically significant difference between the CLNAGC and CLAGC . In relation to GLUT - 3 , was found a statistically significant difference between PGCL and CLAGC and between CLAGC and CLNAGC in amount of mononuclear cells immunomarked . Regarding the intensity of labeling for such protein was found a statistically signifi cant difference at the giant cells between PL and CLAGC . To the M - CSF was observed only a statistically significant difference in the intensity of labeling at the mononuclear cells between PGCL and CLNAGC and between PGCL and CLAGC . Based on these results, we can conclude the participation of GLUT - 1, GLUT - 3 and M - CSF in the pathogenesis of the lesions studied. The bigger immunostaining of these proteins in mononuclear cells show that these cells perform a higher metabolic activity and osteoclastogenic, espe cially in CLAGC . It was found that the mononuclear cells were more related to the pathogenesis of the studied lesions than properly the giant s cell s.
Resumo:
Central giant cell lesion (CGCL) and peripheral giant cell lesion (PGCL) of the jaws have a distinct clinical behavior, although they share histopathologic features. It is still unclear whether these clinical differences are supported by a distinct pattern of immunoexpression of markers for multinucleated giant cells (GC) and mononuclear cells (MC). The purpose of this study was to compare the immunohistochemical expression of VEGF, MMP-9 in CG and MC and measure the vascularization by vWF to check whether there are differences in expression of these biomarkers between CGCL and PGCL. Paraffin wax blocks of 20 cases of LCCG and 20 LPCG were retrieved. MMP-9 immunoreactivity was greater in the CM of PGCL compared to VEGF (p<0.05). VEGF expression was greater in the CM of CGCL compared to PGCL (p<0.05) and it was greater in the overall expression of CGCL compared to PGCL (p<0.05). Vascularity was quantified by microvascular counting (MVC). MVC was greater in the PGCL compared CGCL (p<0.05). MMP-9 showed a greater tendency of expression in CGCL, though was not significant (p>0.05). We tested correlation between the proteins studied in each group and found a significant negative correlation between VEGF and vWF in CGCL (p<0.05). These results suggest that there are differences in the expression of VEGF in CM and overall expression between the lesions, although no statistically significant difference in the overall expression of the MMP-9. Then, there was a trend in increased expression of MMP-9 and VEGF in CGCL, possibly by the involvement of both proteins in osteoclastogenesis. Additionally, the results of this study indicate a higher degree of vascularization in PGCL compared to CGCL, fact that can be directly linked to the reactive nature of the PGCL, where the inflammatory process with its rich angiogenesis contributes significantly to these findings.
Resumo:
The aim of this study was to analyze the immunoexpression of calcitonin (CTR) and glucorticoid (GCR) receptors in aggressive and non-aggressive central giant cell lesions (CGCL). This is an immunohistochemistry study (immunoperoxidase technique) of 52 cases of CGCL of the jaws, in which 12 patients were treated with intralesional triamcinolone injections and one with calcitonin nasal spray. The mean of immunostaining was compared between the cell types and clinical subtype of the lesion. The correlations among means were analyzed by Mann-Whitney test. Of the 52 cases studied, 53.8% were females, with a mean of 25.69 years. Most lesions were located in the mandible. Thirty patients (57.7%) had aggressive lesions and 22 (42.3%) of the cases consisted of non-aggressive lesions. Surgery was the treatment of choice in 75% of the cases. In 56.7% of the aggressive CGCL surgery was performed, while 43.4% of patients were submitted to conservative treatment. Among cases submitted to conservative treatment, the majority (n = 8; 61.5%) responded well to treatment. CTR expression was observed in 67.3% and GCR in 96.15% of cases. There was no significant statistical difference between the expression of CTRs and GCRs in mononuclear and multinucleated CGCLscells, regarding aggressiveness, treatment performed for aggressive lesions and the response to conservative treatment (p>0.05). The results of our research suggest that the immunoreactivity of CTRs and GCRs did not influence the response to clinical treatment with calcitonin or triamcinolone in the sample studied and it exhibited a varied expression regardless of the aggressiveness of the lesion.
Resumo:
The aim of this study was to analyze the immunoexpression of calcitonin (CTR) and glucorticoid (GCR) receptors in aggressive and non-aggressive central giant cell lesions (CGCL). This is an immunohistochemistry study (immunoperoxidase technique) of 52 cases of CGCL of the jaws, in which 12 patients were treated with intralesional triamcinolone injections and one with calcitonin nasal spray. The mean of immunostaining was compared between the cell types and clinical subtype of the lesion. The correlations among means were analyzed by Mann-Whitney test. Of the 52 cases studied, 53.8% were females, with a mean of 25.69 years. Most lesions were located in the mandible. Thirty patients (57.7%) had aggressive lesions and 22 (42.3%) of the cases consisted of non-aggressive lesions. Surgery was the treatment of choice in 75% of the cases. In 56.7% of the aggressive CGCL surgery was performed, while 43.4% of patients were submitted to conservative treatment. Among cases submitted to conservative treatment, the majority (n = 8; 61.5%) responded well to treatment. CTR expression was observed in 67.3% and GCR in 96.15% of cases. There was no significant statistical difference between the expression of CTRs and GCRs in mononuclear and multinucleated CGCLscells, regarding aggressiveness, treatment performed for aggressive lesions and the response to conservative treatment (p>0.05). The results of our research suggest that the immunoreactivity of CTRs and GCRs did not influence the response to clinical treatment with calcitonin or triamcinolone in the sample studied and it exhibited a varied expression regardless of the aggressiveness of the lesion.
Resumo:
Odontoma is a term that refers to a benign tumor of odontogenic and mixed nature, composed of epithelial and mesenchymal components. Histologically, they are compounds of different configurations including dental enamel, dentin, cementum and in some cases the pulp tissue. A slow growing asymptomatic tumor, odontoma is usually discovered through routine radiographic examination. A 3-year old male patient sought care at the School of Dentistry’s Baby Clinic (UNESP-Araçatuba), complaining of “small ball close to the teeth.” During the interview, the mother reported that the lesion was observed soon after a trauma, and evolved in less than one month. An ulcerated lesion with a 0.8 cm diameter was found during intraoral clinical examination. It was located in the inferior and anterior region of the mouth, between teeth 81 and 82, and there was also crown distalization. A radiographic examination showed a radiolucent area and root distance. In the absence of clinical and radiographic characteristics suggesting a case of odontoma, the differential diagnosis was peripheral giant cell lesion and pyogenic granuloma. So the area was punctured. Nonetheless, due to the absence of liquid, the surgical removal of the lesion was performed, followed by histological examination, which showed the definite diagnosis of a suggestive case of emerging odontoma.
Resumo:
O objeto começa abordando as lesões reativas da mucosa bucal, que produzem alteração de volume da mucosa e cessam o crescimento com a remoção do estímulo que desencadeou o processo. Lembra que estímulos físicos, químicos ou biológicos podem produzir uma lesão, dependendo da sua intensidade, do seu tempo de ação e da capacidade de reação individual de cada paciente. Faz uma apresentação sobre o tema, abordando hiperplasia fibrosa inflamatória, fibroma traumático ou de irrigação, granuloma piogênico, fibroma ossificante periférico e lesão periférica de células gigantes. Enfatiza que as lesões reativas da mucosa bucal normalmente são tratadas por meio da remoção cirúrgica. Entretanto, elas necessitam também que haja a remoção do fator etiológico para sua cura plena e para evitar sua recidiva. Finaliza detalhando as lesões neoplásicas da mucosa bucal, que produzem alteração de volume da mucosa por apresentarem crescimento descoordenado (aumentado) em comparação aos tecidos normais e persistirem crescendo mesmo após a cessação do estímulo que as produziu. Unidade 5 do módulo 7 que compõe o Curso de Especialização em Saúde da Família.
Resumo:
Tópico 1 – Lesões brancas da mucosa bucal O tópico aborda as principais lesões brancas presentes na mucosa bucal: candidíase bucal; queimaduras químicas e térmicas; úlceras traumáticas, estomatite, candidíase crônica hiperplásica, queiliteactínica, líquen plano reticular, apresentando: causas, tipologia (removíveis ou não por raspagem), tratamentos possíveis. Tópico 2 - Lesões vermelhas na mucosa bucal O tópico aborda as principais lesões vermelhas presentes na mucosa bucal, destacando a candidíase eritomatosa eritoplástica, mostrando características, aspectos para o diagnóstico diferencial, e tratamento por remoção cirúrgica. Tópico 3 – Lesões pigmentadas da mucosa bucal O tópico apresenta as lesões pigmentadas da mucosa bucal: exógenas e endógenas e a mácula melanóica bucal, suas causas e necessidade ou não de tratamento. Tópico 4 – Lesões que levam à alteração de volume da mucosa bucal O tópico trada de lesões reativas da mucosa bucal, como hiperplasia fibrosa inflamatória, fibroma traumático ou de irritação, granuloma piogênico, fibroma ossificante periférico, lesão periférica de células gigantes, lesões neoplásicas, lipoma, papiloma; suas características e tratamento por remoção cirúrgica. Tópico 5 – Conduta preventiva do câncer bucal O tópico ressalta a relevância que o câncer bucal tem em termos de saúde pública e o papel significativo da AB para sua prevenção. Apresenta as suas características, etiologia, causas, formas de diagnóstico, necessidade de comunicação qualificada com o usuário, fatores de risco, ações de educação em saúde trabalho individual ou coletivo com grupos de apoio, e uma reflexão sobre o tema. Conteúdo Online do módulo de Atenção integral à saúde do adulto: Lesões de mucosa mais frequentes na cavidade bucal. Unidade 4 do módulo 13 para dentista que compõe o Curso de Especialização Multiprofissional em Saúde da Família.
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
O granuloma reparador de células gigantes é lesão óssea rara, correspondendo a cerca de 7% de todos os tumores ósseos benignos da mandíbula, com maior incidência no sexo feminino. Embora seja considerada resposta a um trauma, este antecedente nem sempre está presente. O aspecto radiológico característico é de lesão lítica, uni ou multiloculada, com afilamento da cortical, podendo apresentar calcificações no seu interior. Neste trabalho relatamos os aspectos clínicos e radiológicos de cinco casos de granuloma reparador de células gigantes envolvendo a mandíbula e o maxilar, e as principais características que permitem o diagnóstico diferencial com outras lesões fibro-ósseas que acometem a face.
Resumo:
OBJETIVO: Analisar os aspectos clínicos e radiográficos em pacientes com diagnóstico de tumor de células gigantes ósseo, confirmado por histopatologia. MATERIAIS E MÉTODOS: Os dados clínicos e radiológicos (quando disponíveis) de 115 pacientes com diagnóstico de tumor de células gigantes ósseo foram analisados no presente estudo. RESULTADOS: Dos casos avaliados, 57,4% (66) eram do sexo feminino e 80% (92) eram da raça branca. A média de idade dos pacientes foi de 30 anos e a topografia mais freqüente das lesões foi a metáfise distal do fêmur, em 22,6% (26) dos casos. O aspecto radiográfico mais comum foi o de lesão puramente lítica, em 63,7% (51) dos casos. CONCLUSÃO: O tumor de células gigantes é uma neoplasia óssea relativamente comum, com predomínio em indivíduos da raça branca e com aspecto radiológico bem definido.
Resumo:
O tumor de células gigantes é a sexta neoplasia óssea primária mais comum. Acomete a metáfise de ossos longos, sendo mais comum em adultos jovens. Na radiologia mostra-se como lesão lítica, excêntrica e de limites definidos. Os autores relatam um caso de tumor de células gigantes benigno em paciente que apresentou metástases pulmonares cinco anos após a retirada do tumor primário.
Resumo:
O granuloma reparativo de células gigantes é um tumor ósseo não-neoplásico incomum que representa menos que 7% dos tumores mandibulares, sua localização mais freqüente. Porém, já foi descrito em seios paranasais, ossos temporais e órbita. O presente trabalho descreve um paciente com granuloma reparativo de células gigantes em seios maxilar e etmoidal, comprometendo também, em menor extensão, os seios esfenoidal e frontal, e um outro paciente com acometimento circunscrito ao seio maxilar. Clinicamente, apresentam-se com proptose acentuada e macromala unilaterais, respectivamente. Os achados clínicos, tomográficos, histopatológicos e terapêuticos são descritos, ao lado de uma revisão da literatura com ênfase no diagnóstico diferencial, sobretudo com o tumor de células gigantes.
Resumo:
Arterite de Células Gigantes (ACG) é uma vasculite sistêmica, granulomatosa, mediada por fatores imunitários, envolvendo artérias de grande e médio calibre e afetando preferencialmente idosos. A morte decorrente da ACG é rara e resulta principalmente da ruptura da aorta. Neste trabalho é relatado o caso de paciente de 83 anos, que faleceu inesperadamente, durante tratamento de ACG. A necropsia revelou envolvimento inflamatório das artérias coronárias, com trombose da artéria descendente anterior esquerda, infarto do miocárdio, ruptura da parede anterior do ventrículo esquerdo, hemopericárdio e tamponamento cardíaco. Infarto do miocárdio determinando morte súbita é uma complicação excepcional da ACG.
Resumo:
L’arteritis de cèl•lules gegantes (ACG) és una emergència mèdica i una causa comú de ceguesa en la nostra població major, la qual cosa converteix al oftalmòleg en el responsable del diagnòstic precoç i tractament oportú. Realitzem un estudi retrospectiu de 82 pacients amb sospita clínica de ACG, i es va observar la relació entre les troballes de la biòpsia d'artèria temporal (BAT) amb les troballes clíniques i de laboratori. Trobem que la BAT és poc sensible (50%) i altament específica (100%). 20 (40%) pacients van presentar compromís ocular. El símptoma clínic i el paràmetre de laboratori que es va relacionar amb BAT positiva van ser la claudicació mandibular (P=0,003) i la VSG (P= 0,006) respectivament.